Back

Handa Pharmaceuticals wins FDA approval, shares hit NT$118 daily limit

Verifying
  • Handa Pharmaceuticals received final FDA approval for HND-039 OMCAZIO.
  • Handa shares opened at NT$114.5 and reached the NT$118 daily limit.
  • The FDA rejected the originator company’s April citizen petition after July 30 tentative approval.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.